EDITORIAL
The availability of drugs in the market is facing a new crisis as 40 pharmaceutical companies have warned that they may have to stop production within a week. The root cause of this issue is the dire financial situation of the country that has now started to impact even the most basic necessities of life, adding to the already overwhelming problems faced by the common people.
The pharma manufacturers have sent out an SOS to the relevant state officials, including the health ministry and the Drug Regulatory Authority of Pakistan, highlighting their inability to import raw material for drugs due to the unavailability of dollars and the clogging of containers. Moreover, the freefall of the rupee against the dollar has resulted in skyrocketing production and transportation costs. These are not just complaints from the pharma industry, but from all sectors, yet with the pharma industry, the consequences are especially dire and could mean the difference between life and death.
The health officials have given their word to prevent a shortage of medicines, and the public can only hope that these promises are fulfilled with haste. The impact of such a shortage would be catastrophic, particularly for those who rely on life-saving drugs. The situation is further compounded by the fact that the country is already grappling with a shortage of health workers and inadequate healthcare facilities.
This crisis in the pharma industry is just the tip of the iceberg in the ongoing economic and political turmoil. The country is in dire need of a concerted effort to address the root causes of the problem and find a sustainable solution. The government must take immediate steps to provide the necessary support to the pharma industry to prevent a shortfall in the supply of life-saving drugs.
The specter of a drug shortage is haunting the nation once again, and this time, it’s not just a passing storm. This crisis has been brewing for months and is reaching a boiling point. The root cause, once again, is the dire economic situation that the country finds itself in, but the consequences of such a shortage can be catastrophic, particularly for those who rely on life-saving drugs.
Last year, the country faced a shortage of several essential drugs and even of paracetamol brand Panadol for mostly the same reasons that are plaguing the industry now. The government must include the pharmaceutical industry amongst those sectors that must have priority access to dollars, and shipments waiting at ports need to be cleared immediately to prevent a shortfall in the supply of life-saving drugs.
The long-term solution, however, requires a multi-pronged approach. De-regulation of drug prices, except for life-saving drugs, must be considered to prevent these cyclical crises. Profiteering cannot be allowed, but manufacturers cannot be expected to produce medicines at a loss either. High drug prices are a problem, but non-availability is equally troubling.
The IMF may push for the removal of subsidies, but the state must make efforts to provide highly subsidized or even free quality medicines through government hospitals to the poorest and most vulnerable segments. This is especially crucial in light of the merciless inflationary storm that is hitting the country hard.
In conclusion, the threat of a drug shortage is a matter of grave concern, and the government must take immediate action to prevent a shortfall in the supply of life-saving drugs. A multi-pronged approach is necessary to address this crisis in the long-term, including priority access to dollars, de-regulation of drug prices, and providing subsidised or free medicines to the most vulnerable segments. The health and well-being of the nation cannot be held hostage to the economic crisis, and action must be taken now to prevent a catastrophe.
Read more:
